# Aprea Therapeutics (stock symbol: APRE) Logo in transparent PNG and SVG formats

## Aprea Therapeutics Logo large

### Aprea Therapeutics Logo large Download PNG (85.25 KB)

![Aprea Therapeutics Logo large Download PNG (85.25 KB)](/img/orig/APRE_BIG-2ee88fc7.png)

### Aprea Therapeutics Logo large Download SVG (92.38 KB)

![Aprea Therapeutics Logo large Download SVG (92.38 KB)](/img/orig/APRE_BIG-5c9ecda6.svg)

## Aprea Therapeutics Logo icon format

### Aprea Therapeutics Logo icon format Download PNG (65.26 KB)

![Aprea Therapeutics Logo icon format Download PNG (65.26 KB)](/img/orig/APRE-033c7610.png)

### Aprea Therapeutics Logo icon format Download SVG (32.17 KB)

![Aprea Therapeutics Logo icon format Download SVG (32.17 KB)](/img/orig/APRE-8b65865c.svg)

## About Aprea Therapeutics

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.

1. Website domain: atrinpharma.com
2. Marketcap: $14.79 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
